paclitaxel has been researched along with Glioblastoma with Sarcomatous Component in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PY; Huang, CY; Lin, FW; Wang, CK; Wei, KC; Yang, HW | 1 |
| Basaldella, L; Bekelis, K; Brem, H; Caplan, JM; Fowers, KD; Grossman, R; Hdeib, A; Legnani, F; Li, KW; Pradilla, G; Recinos, VR; Tyler, B | 1 |
| Brem, H; Caplan, J; Fowers, KD; Hdeib, A; Jallo, G; Legnani, FG; Pradilla, G; Tyler, BM | 1 |
| Basile, L; Béjaud, J; Benoit, JP; Huynh, NT; Passirani, C; Pignatello, R; Puglisi, G | 1 |
| Barbarese, E; D'Arrigo, JS; Ho, SY; Simon, RH; Smith-Slatas, C | 1 |
5 other study(ies) available for paclitaxel and Glioblastoma with Sarcomatous Component
| Article | Year |
|---|---|
Rapid
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Disease Models, Animal; Drug Therapy, Combination; Epirubicin; Gliosarcoma; Humans; Hydrogels; Infusion Pumps, Implantable; Magnetic Resonance Imaging; Mice; Neoplasm, Residual; Paclitaxel; Secondary Prevention; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured | 2017 |
A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Drug Delivery Systems; Female; Gels; Gliosarcoma; Injections, Intralesional; Kaplan-Meier Estimate; Neoplasm Transplantation; Paclitaxel; Rats; Rats, Inbred F344; Tissue Distribution | 2010 |
Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Drug Delivery Systems; Female; Gels; Gliosarcoma; Paclitaxel; Paresis; Rats; Rats, Inbred F344; Spinal Cord Neoplasms | 2012 |
Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivative.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chemistry, Pharmaceutical; Colloids; Complement Hemolytic Activity Assay; Drug Carriers; Drug Compounding; Gliosarcoma; Half-Life; Humans; Injections, Intravenous; Liposomes; Macrophages; Mice; Nanocapsules; Nanotechnology; Paclitaxel; Polyethylene Glycols; Rats; Rats, Inbred F344; Rats, Wistar; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical; Tissue Distribution; Tumor Burden | 2012 |
Evaluation of lipid-coated microbubbles as a delivery vehicle for Taxol in brain tumor therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Capsules; Cell Division; Cell Survival; Drug Carriers; Glioma; Gliosarcoma; Humans; Liposomes; Neoplasm Transplantation; Paclitaxel; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1997 |